Capital World Investors Novartis Ag Transaction History

Capital World Investors

$597 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $86,109 - $95,563	909 Added 3.03%	30,941 $3.15 Million
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $25,720 - $29,164	278 Added 0.93%	30,032 $3.03 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $39,294 - $45,569	491 Added 1.68%	29,754 $2.74 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $2.36 Million - $2.89 Million	-31,200 Reduced 51.6%	29,263 $2.65 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $66.3 Million - $77.5 Million	-888,490 Reduced 93.63%	60,463 $4.63 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $34.8 Million - $40.5 Million	431,840 Added 83.51%	948,953 $80.2 Million
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $1.82 Million - $2.05 Million	-22,665 Reduced 4.2%	517,113 $45.4 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $262,372 - $290,123	3,292 Added 0.61%	539,778 $47.2 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $474,896 - $552,477	5,807 Added 1.09%	536,486 $43.9 Million
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $4.12 Million - $4.56 Million	48,391 Added 10.03%	530,679 $48.5 Million
Q1 2021 May 14, 2021	BUY	$83.5 - $98.47 $609,967 - $719,323	7,305 Added 1.54%	482,288 $41.3 Million
Q4 2020 Feb 12, 2021	BUY	$78.07 - $94.43 $9.42 Million - $11.4 Million	120,702 Added 34.07%	474,983 $44.9 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $45.1 Million - $50 Million	-549,458 Reduced 60.8%	354,281 $30.8 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $45.9 Million - $51.6 Million	566,856 Added 168.26%	903,739 $78.9 Million
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $9.69 Million - $13.6 Million	137,138 Added 68.66%	336,883 $27.8 Million
Q4 2019 Feb 18, 2020	BUY	$84.35 - $95.37 $133,273 - $150,684	1,580 Added 0.8%	199,745 $18.9 Million
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $413,500 - $455,652	4,834 Added 2.5%	198,165 $17.2 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $23,826 - $29,324	316 Added 0.16%	193,331 $17.7 Million
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $18.6 Million - $21.3 Million	-247,000 Reduced 56.13%	193,015 $18.6 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $66 - $77	1 Added 0.0%	440,015 $37.9 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $31 Million - $37 Million	440,002 Added 3666683.25%	440,014 $35.6 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $144 - $155	2 Added 20.0%	12 $1,000
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $741 - $772	10	10 $1,000

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.55M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $238B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Account